Liu Chia-Chia, Jan Yee-Jee, Ko Bor-Sheng, Wu Yao-Ming, Liang Shu-Man, Chen Shyh-Chang, Lee Yen-Ming, Liu Tzu-An, Chang Tzu-Ching, Wang John, Shyue Song-Kun, Sung Li-Ying, Liou Jun-Yang
Institute of Biotechnology, National Taiwan University, Taipei 106, Taiwan.
BMC Cancer. 2014 Jun 12;14:425. doi: 10.1186/1471-2407-14-425.
14-3-3σ is implicated in promoting tumor development of various malignancies. However, the clinical relevance of 14-3-3σ in hepatocellular carcinoma (HCC) tumor progression and modulation and pathway elucidation remain unclear.
We investigated 14-3-3σ expression in 109 HCC tissues by immunohistochemistry. Overexpression and knockdown experiments were performed by transfection with cDNA or siRNA. Protein expression and cell migration were determined by Western blot and Boyden chamber assay.
In this study, we found that 14-3-3σ is abundantly expressed in HCC tumors. Stable or transient overexpression of 14-3-3σ induces the expression of heat shock factor-1α (HSF-1α) and heat shock protein 70 (HSP70) in HCC cells. Moreover, expression of 14-3-3σ significantly correlates with HSF-1α/HSP70 in HCC tumors and both 14-3-3σ and HSP70 overexpression are associated with micro-vascular thrombi in HCC patients, suggesting that 14-3-3σ/HSP70 expression is potentially involved in cell migration/invasion. Results of an in vitro migration assay indicate that 14-3-3σ promotes cell migration and that 14-3-3σ-induced cell migration is impaired by siRNA knockdown of HSP70. Finally, 14-3-3σ-induced HSF-1α/HSP70 expression is abolished by the knockdown of β-catenin or activation of GSK-3β.
Our findings indicate that 14-3-3σ participates in promoting HCC cell migration and tumor development via β-catenin/HSF-1α/HSP70 pathway regulation. Thus, 14-3-3σ alone or combined with HSP70 are potential prognostic biomarkers for HCC.
14-3-3σ与多种恶性肿瘤的肿瘤发展相关。然而,14-3-3σ在肝细胞癌(HCC)肿瘤进展、调节及通路阐释方面的临床相关性仍不明确。
我们通过免疫组织化学研究了109例HCC组织中14-3-3σ的表达情况。通过转染cDNA或siRNA进行过表达和敲低实验。采用蛋白质印迹法和博伊登小室实验测定蛋白质表达和细胞迁移情况。
在本研究中,我们发现14-3-3σ在HCC肿瘤中大量表达。14-3-3σ的稳定或瞬时过表达可诱导HCC细胞中热休克因子-1α(HSF-1α)和热休克蛋白70(HSP70)的表达。此外,14-3-3σ的表达与HCC肿瘤中的HSF-1α/HSP70显著相关,且14-3-3σ和HSP70的过表达均与HCC患者的微血管血栓形成有关,这表明14-3-3σ/HSP70的表达可能参与细胞迁移/侵袭。体外迁移实验结果表明,14-3-3σ可促进细胞迁移,而HSP70的siRNA敲低可削弱14-3-3σ诱导的细胞迁移。最后,β-连环蛋白的敲低或GSK-3β的激活可消除14-3-3σ诱导的HSF-1α/HSP70表达。
我们的研究结果表明,14-3-3σ通过β-连环蛋白/HSF-1α/HSP70通路调节参与促进HCC细胞迁移和肿瘤发展。因此,单独的14-3-3σ或与HSP70联合使用可能是HCC的潜在预后生物标志物。